The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
784
January 27, 1989
View Complete Issue         Table of Contents 2019 
Issue 784
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Trimetrexate
January 27, 1989 (Issue: 784)
Trimetrexate glucuronate (Parke-Davis), an investigational drug, is now available in the USA from the National Institute of Allergy and Infectious Diseases (NIAID) for treatment of selected AIDS patients with Pneumocystis carinii pneumonia (PCP)....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 784
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.